Assessment of ocular surface diseases in systemic autoimmune conditions
DOI:
https://doi.org/10.18203/2320-6012.ijrms20243372Keywords:
Anxiety and depression, Autoimmune rheumatic diseases, Systemic autoimmune conditions, Dry eye disease, Ocular surface, Quality of lifeAbstract
Background: Ocular surface inflammation causing dry eye disease (DED) develops in numerous systemic inflammatory/autoimmune conditions. This study aimed to assess the association between ocular surface disorders and psychological and physiological situations among systemic autoimmune patients.
Methods: This cross-sectional study included 60 autoimmune rheumatic patients (120 eyes) visiting the department of ophthalmology at BSMMU, Dhaka, Bangladesh from January 2023 to December 2023. Patients were 18 to 80 years old. Pearson and spearman’s analysis were conducted to examine the relationship between systematic conditions and ocular surface conditions. P<0.05 was regarded as statistically significant.
Results: The analysis considered the age and sex of the participants. In the study, a higher percentage of autoimmune rheumatic patients’ eyes had DED compared to the control group. Autoimmune rheumatic patients also had higher OSDI scores, lower tear secretion, more severe CFS, and conjunctivochalasis. Additionally, they had lower SF-36 scores, higher anxiety, and HAQ-DI scores.
Conclusions: Factors such as quality of life, anxiety, depression, and sleep quality are linked to ocular surface conditions, particularly DED symptoms. The management of systemic conditions and psychotherapy should also be considered as part of the treatment for autoimmune rheumatic patients.
Metrics
References
Sparks JA. Rheumatoid Arthritis. Ann Intern Med. 2019;170:Itc1-16.
Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172:itc81-96.
Mariette X, Criswell LA. Primary Sjögren’s Syndrome. N Engl J Med. 2018;378:931-9.
Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis. J Rheumatol. 2021;48(1):25-34.
Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40:503-10.
Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135-41.
Bjordal O, Norheim KB, Rødahl E, Jonsson R, Omdal R. Primary Sjögren’s syndrome and the eye. Surv Ophthal. 2020;65(2):119-32.
Gomes JAP, Santo RM. The impact of dry eye disease treatment on patient satisfaction and quality of life: a review. Ocul Surf. 2019;17:9-19.
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334-65.
Figueiredo-Braga M, Cornaby C, Cortez A, Bernardes M, Terroso G, Figueiredo M, et al. Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors. Medicine. 2018;97(28):e11376.
Hassan AA, Nasr MH, Mohamed AL, Kamal AM, Elmoghazy AD. Psychological affection in rheumatoid arthritis patients in relation to disease activity. Medicine. 2019;98:e15373.
Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. Sci Rep. 2016;6:22480.
Wu M, Liu X, Han J, Shao T, Wang Y. Association between sleep quality, mood status, and ocular surface characteristics in patients with dry eye disease. Cornea. 2019;38(3):311-7.
Sangle SR, Tench CM, D’Cruz DP. Autoimmune rheumatic disease and sleep: a review. Curr Opin Pulm Med. 2015;21:553-6.
Vitale S, Goodman LA, Reed GF, Smith JA.. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren’s syndrome-related dry eye. Health Qual Life Outcomes. 2004;2:44.
Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539-74.
Pult H, Wolffsohn JS. The development and evaluation of the new ocular surface disease Index-6. Ocul Surf. 2019;17:817-21.
Yarlas A, Bayliss M, Cappelleri JC, Maher S, Bushmakin AG, Chen LA, et al. Psychometric validation of the SF-36(®) Health Survey in ulcerative colitis: results from a systematic literature review. Qual Life Res. 2018;27:273-90.
Owusu-Akyaw KA, Bido J, Warner T, Rodeo SA, Williams RJ. SF-36 physical component score is predictive of achieving a clinically meaningful improvement after osteochondral allograft transplantation of the femur. Cartilage. 2021;13(1_suppl):853S-9S.
Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C, et al. Health assessment questionnaire disability index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. Arthritis Res Ther. 2020;22:257.
Mease P, Strand V, Gladman D. Functional impairment measurement in psoriatic arthritis: Importance and challenges. Semin Arth Rheum. 2018;48:436–48.
Annunziata MA, Muzzatti B, Bidoli E, Flaiban C, Bomben F, Piccinin M, et al. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care in Cancer. 2020;28:3921-6.
Yue T, Li Q, Wang R, Liu Z, Guo M, Bai F, et al. Comparison of hospital anxiety and depression scale (HADS) and Zung self-rating anxiety/depression scale (SAS/SDS) in evaluating anxiety and depression in patients with psoriatic arthritis. Dermatology. 2020;236:170-8.
Kwan A, Marzouk S, Ghanean H, Kishwar A, Anderson N, Bonilla D, et al. Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus. Semin Arthritis Rheum. 2019;49:260-6.
Dietch JR, Taylor DJ, Sethi K, Kelly K, Bramoweth AD, Roane BM. Psychometric evaluation of the PSQI in U.S college students. J Clin Sleep Med. 2016;12:1121-9.
Pilz LK, Keller LK, Lenssen D, Roenneberg T. Time to rethink sleep quality: PSQI scores reflect sleep quality on workdays. Sleep. 2018;41(5).
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arth Rheum. 2010;62:2569-81.
Radner H, Neogi T, Smolen JS, Aletaha D. Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2014;73:114-23.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey‐Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151-9.
Aringer M, Johnson SR. Classifying and diagnosing systemic lupus erythematosus in the 21st century. Rheumatology. 2020;59:v4-11.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9-16.
Ren Y, Tian J, Shi W, Feng J, Liu Y, Kang H, et al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23(1):229.
Downloads
Published
How to Cite
Issue
Section
